• Company
• Lilly applies for listing of its fast-acting insulin Lyumjev
• by Eo, Yun-Ho Jul 3, 2021 05:56am

• Company
• Takeda's Susoctocog alfa has been designated as a rare drug
• by Jul 3, 2021 05:56am

• Company
• Martín Corcoll, Boehringer Ingelheim Korea's new GM
• by Jul 3, 2021 05:56am

• Policy
• The reasons why Hemlibra's benefit was not recognized?
• by Lee, Hye-Kyung Jul 3, 2021 05:56am

• Company
• Opdivo+Yervoy's negotiations failed to reach an agreement
• by Jul 1, 2021 05:56am

• Company
• Yuhan’s Leclaza reimb. held back by companion diagnostics
• by Eo, Yun-Ho Jul 1, 2021 05:56am

• Policy
• Rationalizing ICER threshold requires various considerations
• by Kim, Jung-Ju Jul 1, 2021 05:56am

• Company
• Hanmi’s Efpeglenatide reduces cardiovascular risk
• by Chon, Seung-Hyun Jul 1, 2021 05:55am

• Policy
• Targets for PVA in third quarter include Darzalex & Alunbrig
• by Lee, Hye-Kyung Jul 1, 2021 05:55am

• Company
• Generics for Pradaxa, Xarelto & Brilinta will be released
• by Kim, Jin-Gu Jun 30, 2021 05:57am